Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 298

1.

Gut--liver axis: the impact of gut microbiota on non alcoholic fatty liver disease.

Compare D, Coccoli P, Rocco A, Nardone OM, De Maria S, Cartenì M, Nardone G.

Nutr Metab Cardiovasc Dis. 2012 Jun;22(6):471-6. doi: 10.1016/j.numecd.2012.02.007. Epub 2012 Apr 28. Review.

PMID:
22546554
2.

Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders.

Musso G, Gambino R, Cassader M.

Curr Opin Lipidol. 2010 Feb;21(1):76-83. doi: 10.1097/MOL.0b013e3283347ebb. Review.

3.

Gut microbiota and liver disease.

Goel A, Gupta M, Aggarwal R.

J Gastroenterol Hepatol. 2014 Jun;29(6):1139-48. doi: 10.1111/jgh.12556. Review.

PMID:
24547986
4.

Gut-liver axis and microbiota in NAFLD: insight pathophysiology for novel therapeutic target.

Miele L, Marrone G, Lauritano C, Cefalo C, Gasbarrini A, Day C, Grieco A.

Curr Pharm Des. 2013;19(29):5314-24. Review.

PMID:
23432669
5.

Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury.

Frazier TH, DiBaise JK, McClain CJ.

JPEN J Parenter Enteral Nutr. 2011 Sep;35(5 Suppl):14S-20S. doi: 10.1177/0148607111413772. Epub 2011 Aug 1. Review.

PMID:
21807932
6.

Gut-liver axis and sensing microbes.

Szabo G, Bala S, Petrasek J, Gattu A.

Dig Dis. 2010;28(6):737-44. doi: 10.1159/000324281. Epub 2011 Apr 27. Review.

7.

Nonalcoholic fatty liver disease: for better or worse, blame the gut microbiota?

Li DY, Yang M, Edwards S, Ye SQ.

JPEN J Parenter Enteral Nutr. 2013 Nov;37(6):787-93. doi: 10.1177/0148607113481623. Epub 2013 Mar 28. Review.

PMID:
23538296
8.

Probiotics in non-alcoholic fatty liver disease: which and when.

Abenavoli L, Scarpellini E, Rouabhia S, Balsano C, Luzza F.

Ann Hepatol. 2013 May-Jun;12(3):357-63. Review.

9.

Gut microbiota drives metabolic disease in immunologically altered mice.

Chassaing B, Aitken JD, Gewirtz AT, Vijay-Kumar M.

Adv Immunol. 2012;116:93-112. doi: 10.1016/B978-0-12-394300-2.00003-X. Review.

PMID:
23063074
10.

Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease.

Paolella G, Mandato C, Pierri L, Poeta M, Di Stasi M, Vajro P.

World J Gastroenterol. 2014 Nov 14;20(42):15518-31. doi: 10.3748/wjg.v20.i42.15518. Review.

11.

Effects of the gut microbiota on obesity and glucose homeostasis.

Greiner T, Bäckhed F.

Trends Endocrinol Metab. 2011 Apr;22(4):117-23. doi: 10.1016/j.tem.2011.01.002. Epub 2011 Feb 23. Review.

PMID:
21353592
12.

Gut microbiota and non-alcoholic fatty liver disease: new insights.

Aron-Wisnewsky J, Gaborit B, Dutour A, Clement K.

Clin Microbiol Infect. 2013 Apr;19(4):338-48. doi: 10.1111/1469-0691.12140. Epub 2013 Mar 2. Review.

13.

Probiotics in the treatment of non alcoholic fatty liver disease: further evidence in obese children.

Vajro P, Veropalumbo C, D'Aniello R, Mandato C.

Nutr Metab Cardiovasc Dis. 2013 Jan;23(1):e9-10. doi: 10.1016/j.numecd.2012.10.006. Epub 2012 Nov 21. No abstract available.

PMID:
23177179
14.

Structural changes of gut microbiota in a rat non-alcoholic fatty liver disease model treated with a Chinese herbal formula.

Yin X, Peng J, Zhao L, Yu Y, Zhang X, Liu P, Feng Q, Hu Y, Pang X.

Syst Appl Microbiol. 2013 May;36(3):188-96. doi: 10.1016/j.syapm.2012.12.009. Epub 2013 Mar 1.

PMID:
23453736
15.

Microbiota and gut-liver axis: their influences on obesity and obesity-related liver disease.

Vajro P, Paolella G, Fasano A.

J Pediatr Gastroenterol Nutr. 2013 May;56(5):461-8. doi: 10.1097/MPG.0b013e318284abb5. Review.

16.

Gut-liver axis, nutrition, and non-alcoholic fatty liver disease.

Kirpich IA, Marsano LS, McClain CJ.

Clin Biochem. 2015 Sep;48(13-14):923-30. doi: 10.1016/j.clinbiochem.2015.06.023. Epub 2015 Jul 4. Review.

17.

Gut microbiota and non-alcoholic fatty liver disease.

Gkolfakis P, Dimitriadis G, Triantafyllou K.

Hepatobiliary Pancreat Dis Int. 2015 Dec;14(6):572-81. Review.

PMID:
26663004
18.

Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice.

De Minicis S, Rychlicki C, Agostinelli L, Saccomanno S, Candelaresi C, Trozzi L, Mingarelli E, Facinelli B, Magi G, Palmieri C, Marzioni M, Benedetti A, Svegliati-Baroni G.

Hepatology. 2014 May;59(5):1738-49. doi: 10.1002/hep.26695. Epub 2014 Feb 25.

PMID:
23959503
19.

Gut-liver axis and fibrosis in nonalcoholic fatty liver disease: an input for novel therapies.

Frasinariu OE, Ceccarelli S, Alisi A, Moraru E, Nobili V.

Dig Liver Dis. 2013 Jul;45(7):543-51. doi: 10.1016/j.dld.2012.11.010. Epub 2012 Dec 29. Review.

PMID:
23280158
20.

Gut microbiota-related complications in cirrhosis.

Gómez-Hurtado I, Such J, Sanz Y, Francés R.

World J Gastroenterol. 2014 Nov 14;20(42):15624-31. doi: 10.3748/wjg.v20.i42.15624. Review.

Supplemental Content

Support Center